MichaelPatrickLoweMD

Cancer Genetics/Cancer Risk Assessment, Gynecologic Cancer

M. Patrick Lowe, M.D., is a founding partner in the Gynecologic Cancer Institute of Chicago. Dr. Lowe is the Director of Gynecologic Oncology and Robotic Surgery Program at Advocate Christ Medical Center. Dr Lowe is an Assistant Professor at the Univ of Illinois at Chicago. Dr Lowe is the former Founder and Director of Robotic Surgery Program at Northwestern Prentice Hospital. www.gcichicago.com

Join to view full profile

Dr. Lowe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lowe's full profile

Already have an account?

Office
6700 W 95th St
Ste 330
Oak Lawn, IL 60453
Phone+1 708-422-3242

Fax+1 708-422-3243

Education & Training

Institut Claudius RegaudLaparoscopy, Visiting Fellowship, 2007 - 2007
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gynecologic Oncology, 2002 - 2005
University of Iowa Hospitals and ClinicsResidency, Obstetrics and Gynecology, 1998 - 2002
University of Alabama School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 2002 - Present
IL State Medical License 2007 - 2026
FL State Medical License 2012 - 2020
TN State Medical License 2005 - 2009
AR State Medical License 2005 - 2008
IA State Medical License 1998 - 2002
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

3 citations
Stabilization of Metastatic Uterine Leiomyosarcoma Using Pembrolizumab.
Katherine Cotangco, Mary Meram, M Patrick Lowe
Journal of the National Comprehensive Cancer Network. 2020-08-01
25 citations
Human ovarian tissue cortex surrounding benign and malignant lesions.
Mary Ellen Pavone, Jennifer Hirshfeld-Cytron, Candace Tingen, Cristina Thomas, Jessina Thomas
Reproductive Sciences. 2014-05-01
40 citations
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal ca...
Todd Tillmanns, M. Patrick Lowe, Mark S. Walker, Edward J. Stepanski, Lee S. Schwartzberg
Gynecologic Oncology. 2013-02-01

Lectures

Pilot integrated biomarker study of VX15/2503 in combination with ipilimumab and/or nivolumab in patients with resectable metastatic melanoma.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

Stage IV Melanoma: What Current Role Should Surgery Play?September 10th, 2019
Injecting Genetically Modified Virus into Tumor May Treat Metastatic MelanomaJanuary 31st, 2019
From Pregnancy to Cancer-Free: Christina Welcomes Baby and Survives Skin CancerJuly 5th, 2023